Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 1817

Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles. It is also termed as Lou Gehrig’s disease. There are several causes behind ALS which includes gene mutation, disorganized immune response, chemical imbalance etc. The symptoms for ALS mainly include fasciculation, respiratory problems, muscles weakness and cramps. The mortality rate in the ALS patients in high due to breathing problem. 
Increasing in the number of patients affected with ALS is one of the major factor to drive the growth of ALS treatment market. Sporadic and familial are two types of ALS disease, in which sporadic disease is most common disease found with 90–95% of the overall cases in US and the government initiatives to examination the research for rare disease and FDA approvals creates an opportunity for various market players due to which the global market of amyotrophic lateral sclerosis treatment is expected to expand at healthy CAGR during the forecast period. Due to lower prevalence rate, awareness about the disease and low treatment availability hinder the growth of ALS treatment market.  
In 2018, the global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment development in United States, Europe and China.

The key players covered in this study
GNT Pharma
Amkor Pharma
Synthetic Biologics
Mitsubishi Tanabe Pharma
Avicena
Sanofi
...

Market segment by Type, the product can be split into
Chemotherapy
Stem Cell Therapy

Market segment by Application, split into
Hospitals
Diagnostic Centres
Clinics
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Stem Cell Therapy
1.5 Market by Application
1.5.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Diagnostic Centres
1.5.4 Clinics
1.5.5 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size
2.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions (2014-2025)
2.2.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Manufacturers
3.1.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players Head office and Area Served
3.3 Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product/Solution/Service
3.4 Date of Enter into Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2014-2019)
4.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2014-2019)
5.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in United States
5.3 United States Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
5.4 United States Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application

6 Europe
6.1 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2014-2019)
6.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Europe
6.3 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
6.4 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application

7 China
7.1 China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2014-2019)
7.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in China
7.3 China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
7.4 China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application

8 Japan
8.1 Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2014-2019)
8.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Japan
8.3 Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
8.4 Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2014-2019)
9.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
9.4 Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application

10 India
10.1 India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2014-2019)
10.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in India
10.3 India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
10.4 India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2014-2019)
11.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Central & South America
11.3 Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type
11.4 Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application

12 International Players Profiles
12.1 GNT Pharma
12.1.1 GNT Pharma Company Details
12.1.2 Company Description and Business Overview
12.1.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
12.1.4 GNT Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
12.1.5 GNT Pharma Recent Development
12.2 Amkor Pharma
12.2.1 Amkor Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
12.2.4 Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
12.2.5 Amkor Pharma Recent Development
12.3 Synthetic Biologics
12.3.1 Synthetic Biologics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
12.3.4 Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
12.3.5 Synthetic Biologics Recent Development
12.4 Mitsubishi Tanabe Pharma
12.4.1 Mitsubishi Tanabe Pharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
12.4.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
12.4.5 Mitsubishi Tanabe Pharma Recent Development
12.5 Avicena
12.5.1 Avicena Company Details
12.5.2 Company Description and Business Overview
12.5.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
12.5.4 Avicena Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
12.5.5 Avicena Recent Development
12.6 Sanofi
12.6.1 Sanofi Company Details
12.6.2 Company Description and Business Overview
12.6.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
12.6.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2014-2019)
12.6.5 Sanofi Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details